Next Science is trading at 0.015 as of the 9th of February 2026. This is a 50.00 percent increase since the beginning of the trading day. The stock's lowest day price was 0.015. Next Science has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 11th of November 2025 and ending today, the 9th of February 2026. Click here to learn more.
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia. The company has 214.79 M outstanding shares. More on Next Science Limited
Next Science Limited [NXSCF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 112.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Next Science's market, we take the total number of its shares issued and multiply it by Next Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Next Science Limited classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 214.79 M outstanding shares.
Next Science Limited has accumulated about 11.06 M in cash with (8.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Next Science Probability Of BankruptcyOwnership AllocationNext Science Limited maintains a total of 214.79 Million outstanding shares. Next Science Limited holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Next Ownership Details
About 53.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.05. Next Science Limited had not issued any dividends in recent years. Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia. Next Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Next Science Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Next Science Limited contact Judith MBA at 61 2 8607 5126 or learn more at https://www.nextscience.com.
Next Science Limited Investment Alerts
Next Science Limited generated a negative expected return over the last 90 days
Next Science Limited has some characteristics of a very speculative penny stock
The company reported the revenue of 8.95 M. Net Loss for the year was (9.35 M) with profit before overhead, payroll, taxes, and interest of 6.94 M.
Next Science Limited has accumulated about 11.06 M in cash with (8.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 53.0% of the company outstanding shares are owned by corporate insiders
Next Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 112.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Next Science's market, we take the total number of its shares issued and multiply it by Next Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Next Profitablity
The company has Profit Margin (PM) of (1.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.14.
Technical Drivers
As of the 9th of February, Next Science secures the Mean Deviation of 7.67, downside deviation of 45.51, and Risk Adjusted Performance of 0.0569. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Next Science Limited, as well as the relationship between them. Please verify Next Science Limiteddownside deviation and the relationship between the information ratio and expected short fall to decide if Next Science Limited is priced some-what accurately, providing market reflects its recent price of 0.015 per share. As Next Science Limited appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.
The output start index for this execution was zero with a total number of output elements of sixty-one. Next Science Limited Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Next Science price patterns.
Next Science Predictive Daily Indicators
Next Science intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Next Science pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Next Science's time-series forecasting models are one of many Next Science's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Next Science's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Next Science without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Next Science financial ratios help investors to determine whether Next Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Next with respect to the benefits of owning Next Science security.